Literature DB >> 21899462

BRAF mutations in hairy-cell leukemia.

Animesh Pardanani, Ayalew Tefferi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21899462     DOI： 10.1056/NEJMc1108130

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis.

Authors:  H Hägglund; B Sander; A Ahmadi; T Gülen; G Nilsson
Journal:  Med Oncol       Date:  2014-07-18       Impact factor: 3.064

2.  Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report.

Authors:  Naoto Imoto; Daisuke Koyama; Isamu Sugiura; Shingo Kurahashi
Journal:  Medicine (Baltimore)       Date:  2021-02-05       Impact factor: 1.817

3.  BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.

Authors:  Valentina Pettirossi; Alessia Santi; Elisa Imperi; Guido Russo; Alessandra Pucciarini; Barbara Bigerna; Gianluca Schiavoni; Elisabetta Fortini; Ariele Spanhol-Rosseto; Paolo Sportoletti; Roberta Mannucci; Maria Paola Martelli; Ludger Klein-Hitpass; Brunangelo Falini; Enrico Tiacci
Journal:  Blood       Date:  2014-12-05       Impact factor: 22.113

4.  Hairy cell leukemia: short review, today's recommendations and outlook.

Authors:  V Maevis; U Mey; G Schmidt-Wolf; I G H Schmidt-Wolf
Journal:  Blood Cancer J       Date:  2014-02-14       Impact factor: 11.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.